Back to search

Increased Risk of Necrotizing Enterocolitis in Premature Infants with Patent Ductus Arteriosus Treated with Indomethacin

Data up to Jan 2025

Published1996
Citations174
References25

Total Citations Per Year

Abstract

References (25)

Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

1983 • 558 citations

Prevention of Necrotizing Enterocolitis in Low-Birth-Weight Infants by IgA–IgG Feeding

1988 • 318 citations

Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial

1990 • 191 citations

Early Ibuprofen Administration to Prevent Patent Ductus Arteriosus in Premature Newborn Infants

1996 • 182 citations

Prophylactic Indomethacin Therapy for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants

1982 • 182 citations

A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia

1994 • 177 citations

A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy

1994 • 161 citations

Gastrointestinal perforation following indomethacin therapy in very low birth weight infants

1981 • 154 citations

Spontaneous, isolated intestinal perforations in neonates with birth weight < 1,000 g not associated with necrotizing enterocolitis

1991 • 123 citations

Changing Trends in Necrotizing Enterocolitis

1991 • 119 citations

Indications for operation in necrotizing enterocolitis revisited

1994 • 116 citations

Localized intestinal perforations after enteral administration of indomethacin in premature infants

1985 • 114 citations

Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g

1993 • 103 citations

Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin

1988 • 96 citations

Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen

1979 • 89 citations

Clinical Comparison of Localized Intestinal Perforation and Necrotizing Enterocolitis in Neonates

1994 • 88 citations

Comparative effects of Indomethacin, Prostaglandin E1, and Ibuprofen on bowel ischemia

1983 • 67 citations

Hemodynamically significant PDA: An echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance

1985 • 67 citations

Granulocyte Macrophage Colony-Stimulating Factor Improves Survival in Two Models of Gut-Derived Sepsis by Improving Gut Barrier Function and Modulating Bacterial Clearance

1994 • 63 citations

Intestinal perforation associated with indomethacin treatment in premature infants

1985 • 42 citations

Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants

1996 • 37 citations

Management of Patent Ductus Arteriosus in the Premature Infant: Indomethacin versus Ligation

1983 • 34 citations

Intravenous Indomethacin therapy in preterm neonates with patent ductus arteriosus

1991 • 32 citations

The protective role of enteral IgA supplementation in neonatal gut origin sepsis

1995 • 32 citations

Gastric perforation associated with indomethacin therapy in a pre-term infant.

1980 • 5 citations

Cited By (0)

No citing papers found in database

Increased Risk of Necrotizing Enterocolitis in Premature Infants with Patent Ductus… (1996) – Annals of Surgery | Metascience Observatory Explorer